Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,809 | 15,887 | 5,881 | 7,839 | 8,053 |
| Receivables | 1,404 | 1,249 | 2,876 | 3,303 | 4,185 |
| TOTAL | $15,180 | $18,000 | $9,892 | $12,091 | $14,334 |
| Non-Current Assets | |||||
| PPE Net | 15 | 16 | 17 | 15 | 18 |
| Intangibles | 2,307 | 2,332 | 2,357 | 2,382 | 2,408 |
| Other Non-Current Assets | 39 | 60 | 78 | 97 | 118 |
| TOTAL | $2,361 | $2,408 | $2,452 | $2,494 | $2,543 |
| Total Assets | $17,541 | $20,408 | $12,343 | $14,585 | $16,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,617 | 3,274 | 1,667 | 1,380 | 904 |
| TOTAL | $5,657 | $3,335 | $1,747 | $1,459 | $984 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47 | 48 | 47 | 68 | 90 |
| TOTAL | $47 | $48 | $47 | $68 | $90 |
| Total Liabilities | $5,704 | $3,383 | $1,794 | $1,526 | $1,074 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,210 | 2,210 | 1,968 | 1,932 | 1,894 |
| Common Shares | 40,264 | 40,264 | 36,116 | 34,888 | 34,627 |
| Retained earnings | -41,231 | -35,444 | -30,874 | -26,496 | -22,810 |
| Other shareholders' equity | -126 | -160 | -173 | -205 | -20 |
| TOTAL | $11,837 | $17,024 | $10,549 | $13,058 | $15,804 |
| Total Liabilities And Equity | $17,541 | $20,408 | $12,343 | $14,585 | $16,877 |